Drugs / Enterovirus Type 71 Vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT05913024 | Oct 2021 → Oct 2022 | — | Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Enterovirus Type 71 Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05913024 ↗ |
| Modality | Vaccine | “experimental vaccine” NCT05913024 ↗ |